What is the current valuation of the South America preclinical CRO market?

As of 2024, the South America preclinical CRO market was valued at 0.657 USD Billion. Read More

What is the projected market size for the South America preclinical CRO market by 2035?

The market is expected to reach a valuation of 1.2 USD Billion by 2035. Read More

What is the expected CAGR for the South America preclinical CRO market during the forecast period?

The anticipated CAGR for the market from 2025 to 2035 is 5.62%. Read More

Which companies are considered key players in the South America preclinical CRO market?

Key players include Charles River Laboratories, Covance, Eurofins Scientific, PRA Health Sciences, Wuxi AppTec, Syneos Health, Medpace, and KCR. Read More

What are the primary applications in the South America preclinical CRO market?

The main applications include Toxicology Testing, Pharmacokinetics, Pharmacodynamics, and Safety Assessment. Read More

How does the Toxicology Testing segment perform in terms of market valuation?

The Toxicology Testing segment was valued between 0.25 and 0.45 USD Billion in 2024. Read More

What services are offered in the South America preclinical CRO market?

Services include In Vivo Services, In Vitro Services, Bioanalytical Services, and Regulatory Services. Read More

What is the market valuation range for In Vivo Services?

In Vivo Services were valued between 0.25 and 0.45 USD Billion in 2024. Read More

Which therapeutic areas are prominent in the South America preclinical CRO market?

Prominent therapeutic areas include Oncology, Cardiovascular, Neurology, and Infectious Diseases. Read More

What is the expected market performance for Dose Escalation Studies?

Dose Escalation Studies are projected to have a valuation range of 0.131 to 0.25 USD Billion. Read More

South America Preclinical CRO Market

ID: MRFR/HS/47588-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

South America Preclinical CRO Market Research Report By Service Type (Biologics Testing, Small Molecule Testing, Toxicology Testing, Pharmacology Testing), By Therapeutic Area (Oncology, Neurology, Cardiology, Infectious Diseases), By Validation Type (In Vivo Studies, In Vitro Studies, Comparative Studies, Regulatory Studies), By End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions, Research Organizations) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035

South America Preclinical CRO Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Billion)
  1. 4.1.1 Toxicology Testing
  2. 4.1.2 Pharmacokinetics
  3. 4.1.3 Pharmacodynamics
  4. 4.1.4 Safety Assessment
2. 4.2 Healthcare, BY Service Type (USD Billion)
  1. 4.2.1 In Vivo Services
  2. 4.2.2 In Vitro Services
  3. 4.2.3 Bioanalytical Services
  4. 4.2.4 Regulatory Services
3. 4.3 Healthcare, BY Therapeutic Area (USD Billion)
  1. 4.3.1 Oncology
  2. 4.3.2 Cardiovascular
  3. 4.3.3 Neurology
  4. 4.3.4 Infectious Diseases
4. 4.4 Healthcare, BY Study Design (USD Billion)
  1. 4.4.1 Single Dose Studies
  2. 4.4.2 Multiple Dose Studies
  3. 4.4.3 Dose Escalation Studies
  4. 4.4.4 Long-Term Studies
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Charles River Laboratories (BR)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Covance (BR)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Eurofins Scientific (BR)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 PRA Health Sciences (BR)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Wuxi AppTec (BR)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Syneos Health (BR)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Medpace (BR)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 KCR (BR)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY SERVICE TYPE
4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY THERAPEUTIC AREA
5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY STUDY DESIGN
6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF HEALTHCARE
9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
12. 6.12 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
13. 6.13 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
14. 6.14 HEALTHCARE, BY SERVICE TYPE, 2024 (% SHARE)
15. 6.15 HEALTHCARE, BY SERVICE TYPE, 2024 TO 2035 (USD Billion)
16. 6.16 HEALTHCARE, BY THERAPEUTIC AREA, 2024 (% SHARE)
17. 6.17 HEALTHCARE, BY THERAPEUTIC AREA, 2024 TO 2035 (USD Billion)
18. 6.18 HEALTHCARE, BY STUDY DESIGN, 2024 (% SHARE)
19. 6.19 HEALTHCARE, BY STUDY DESIGN, 2024 TO 2035 (USD Billion)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
  2. 7.2.2 BY SERVICE TYPE, 2026-2035 (USD Billion)
  3. 7.2.3 BY THERAPEUTIC AREA, 2026-2035 (USD Billion)
  4. 7.2.4 BY STUDY DESIGN, 2026-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South America Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2022-2035)

Toxicology Testing
Pharmacokinetics
Pharmacodynamics
Safety Assessment

Healthcare By Service Type (USD Billion, 2022-2035)

In Vivo Services
In Vitro Services
Bioanalytical Services
Regulatory Services

Healthcare By Therapeutic Area (USD Billion, 2022-2035)

Oncology
Cardiovascular
Neurology
Infectious Diseases

Healthcare By Study Design (USD Billion, 2022-2035)

Single Dose Studies
Multiple Dose Studies
Dose Escalation Studies
Long-Term Studies

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”